Viral vector: potential therapeutic for glioblastoma multiforme
Authors:
- 18 July 2019
- journal article
- review article
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 27 (5) , 270-279
Abstract
Glioblastoma multiforme is a highly malignant primary brain tumour found in adults and is highlighted as the most devastating among all the other grades of glioma. Well-established standard treatment methods, such as chemotherapy, radiation and surgery, have resulted in modest improvement in the survival of patients. Hence, the arduous search for novel treatments backed by advancements in molecular biology still persists. Glioblastoma has many distinctive characteristics, which makes it a potential candidate for gene therapy. Gene therapy involves the delivery of genetic material of therapeutic use into tumour cells, which produces a specific antitumour response. Moreover, viruses stimulate a vigorous cytotoxic effect, they are easily modifiable and the inherent property of horizontal transfer of genetic material makes them valuable tools for genetic engineering. In this review, we have enlisted the various viral vectors employed in gene therapy for glioblastoma.Keywords
Funding Information
- Department of Biotechnology, Ministry of Science and Technology (BT/PR19625/MED/30/1703/2016)
This publication has 75 references indexed in Scilit:
- Brain tumor eradication and prolonged survival from intratumoral conversion of 5-fluorocytosine to 5-fluorouracil using a nonlytic retroviral replicating vectorNeuro-Oncology, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Gene therapy-mediated delivery of targeted cytotoxins for glioma therapeuticsProceedings of the National Academy of Sciences, 2010
- Regression of advanced rat and human gliomas by local or systemic treatment with oncolytic parvovirus H-1 in rat modelsNeuro-Oncology, 2010
- Joint NCCTG and NABTC prognostic factors analysis for high-grade recurrent gliomaNeuro-Oncology, 2009
- Combinatorial Control of Suicide Gene Expression by Tissue-specific Promoter and microRNA Regulation for Cancer TherapyMolecular Therapy, 2009
- High Mobility Group Box2 Promoter-controlled Suicide Gene Expression Enables Targeted Glioblastoma TreatmentMolecular Therapy, 2009
- Controlling brain tumor growth by intraventricular administration of an AAV vector encoding IFN-βCancer Gene Therapy, 2009
- Comprehensive genomic characterization defines human glioblastoma genes and core pathwaysNature, 2008
- The 2007 WHO Classification of Tumours of the Central Nervous SystemActa Neuropathologica, 2007